Skip to main content

Table 3 Factors associated with infection outcomes per course of chemotherapy (N = 157)

From: Infections in children with down syndrome and acute myeloid leukemia: a report from the Canadian infections in AML research group

  Microbiologically documented sterile site infection Bacteremia Clinically documented infection
  Odds ratio (CI) P value Odds ratio (CI) P value Odds ratio (CI) P value
Down syndrome-specific treatment protocol 0.42 (0.28, 0.64) <0.0001 0.48 (0.29, 0.78) 0.003 0.25 (0.10, 0.60) 0.002
Age in years 1.01 (0.99, 1.03) 0.349 1.01 (0.98, 1.03) 0.577 1.01 (0.99, 1.03) 0.261
Diagnosed prior to January 1, 2000 0.79 (0.60, 1.03) 0.080 0.75 (0.56, 1.00) 0.052 0.95 (0.75, 1.22) 0.703
Cumulative dose of cytarabine (g/m2) 1.03 (1.02, 1.05) 0.0001 1.03 (1.01, 1.05) 0.001 0.99 (0.97, 1.01) 0.184
Neutropenia (ANC <0.5 ×109) at start of course 1.01 (0.72, 1.43) 0.936 0.82 (0.56, 1.22) 0.336 1.88 (1.38, 2.56) <0.0001
Greater than 15 days with neutropenia 2.50 (1.89, 3.32) <0.0001 2.45 (1.83, 3.36) <0.0001 2.81 (2.16, 3.66) <0.0001
Days receiving steroids 1.08 (1.06, 1.11) <0.0001 1.07 (1.05, 1.10) <0.0001 1.07 (1.05, 1.09) <0.0001
  1. Abbreviations: ANC absolute neutrophil count, CI confidence interval.